PNC Financial Services Group’s Ginkgo Bioworks DNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.2K	Buy	359 +294	+452%	+$2.44K	﹤0.01%	4550
2025 Q4	$540	Sell	65 -151	-70%	-$1.63K	﹤0.01%	4818
2025 Q3	$3.15K	Sell	216 -28	-11%	-$335	﹤0.01%	4370
2025 Q2	$2.75K	Sell	244 -34	-12%	-$263	﹤0.01%	4320
2025 Q1	$1.58K	Sell	278 -200	-42%	-$2.04K	﹤0.01%	4406
2024 Q4	$4.69K	Hold	478	–	–	﹤0.01%	4055
2024 Q3	$3.9K	Sell	478 -72	-13%	-$721	﹤0.01%	4111
2024 Q2	$7.35K	Sell	550 -397	-42%	-$11.8K	﹤0.01%	3883
2024 Q1	$44K	Buy	947 +31	+3%	+$1.6K	﹤0.01%	3050
2023 Q4	$61.9K	Buy	916 +114	+14%	+$6.98K	﹤0.01%	2860
2023 Q3	$58.1K	Buy	802 +175	+28%	+$14K	﹤0.01%	2874
2023 Q2	$46.6K	Buy	627 +49	+8%	+$2.9K	﹤0.01%	3094
2023 Q1	$30.7K	Sell	578 -400	-41%	-$25.3K	﹤0.01%	3262
2022 Q4	$66.1K	Sell	978 -152	-13%	-$14K	﹤0.01%	2811
2022 Q3	$142K	Buy	1,130 +552	+96%	+$65.8K	﹤0.01%	2311
2022 Q2	$55K	Buy	578 +284	+97%	+$34.6K	﹤0.01%	2932
2022 Q1	$47K	Buy	294 +194	+194%	+$37.8K	﹤0.01%	3142
2021 Q4	$34K	Buy	+100	New	+$47.5K	﹤0.01%	3314